Utilization of cross-linked laccase aggregates in a perfusion basket reactor for the continuous elimination of endocrine-disrupting chemicals.
about
Hybrid magnetic cross-linked enzyme aggregates of phenylalanine ammonia lyase from Rhodotorula glutinis.Quantification of the influence of extracellular laccase and intracellular reactions on the isomer-specific biotransformation of the xenoestrogen technical nonylphenol by the aquatic hyphomycete Clavariopsis aquaticaImmobilization of cross-linked phenylalanine ammonia lyase aggregates in microporous silica gel.Biological and enzymatic treatment of bisphenol A and other endocrine disrupting compounds: a review.Laccase immobilization and insolubilization: from fundamentals to applications for the elimination of emerging contaminants in wastewater treatment.Optimization protocols and improved strategies of cross-linked enzyme aggregates technology: current development and future challenges.Laccases to take on the challenge of emerging organic contaminants in wastewater.Recent developments in the use of tyrosinase and laccase in environmental applications.Biocatalysis engineering: the big picture.Biotransformation of Endocrine-Disrupting Compounds in Groundwater: Bisphenol A, Nonylphenol, Ethynylestradiol and Triclosan by a Laccase Cocktail from Pycnoporus sanguineus CS43.Biodegradation of bisphenols with immobilized laccase or tyrosinase on polyacrylonitrile beads.Bioinspired production of magnetic laccase-biotitania particles for the removal of endocrine disrupting chemicals.Production of superparamagnetic nanobiocatalysts for green chemistry applications.Radio frequency glow discharge-induced acidification of fluoropolymers.Sorption-assisted surface conjugation: a way to stabilize laccase enzymeCoupling Chemical Modification and Immobilization to Improve the Catalytic Performance of Enzymes
P2860
Q33604627-3DA529F4-6021-4E1C-AF5E-49D452678A1FQ34980222-AFED092A-0DDA-47AB-82EE-10E51688DB4CQ35049131-34B1AB2D-4DF9-40D0-A40F-C16103DB3AA7Q38019949-B5F6EE7F-8515-4DC2-B9CE-5D7F99CD30FCQ38050853-3848ACFD-8FFD-480F-AF83-3974EDF7B3E6Q38124123-FA02B1DE-1ED2-43A6-8950-0A767AA53F62Q38264078-3198EAFE-0D42-44A3-9674-59251B2E50E1Q38741427-2368DEE9-670A-4E24-8A26-0B3BD1616E0FQ39176014-28E36E0F-0227-454D-8AB2-41B94B2A4018Q41150192-ABD3178E-0CCD-4C75-8B9E-619801ECE97FQ42787675-6445FD0A-964E-4458-9BD5-2D9125CC7A9BQ43334325-4767F794-1A81-4068-A94F-B83E4140F66EQ50229220-1DE265C0-4C85-4CF3-9A6E-753C53210AD2Q54476554-5396ED1D-969B-4DF8-8FF6-2123689D4078Q57880727-01241F8E-A4D8-4B91-BE85-880747D475E3Q58882095-2D7DDC26-0FAC-41FC-B57D-AEB7673F5B5A
P2860
Utilization of cross-linked laccase aggregates in a perfusion basket reactor for the continuous elimination of endocrine-disrupting chemicals.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@en
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@nl
type
label
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@en
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@nl
prefLabel
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@en
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@nl
P356
P1476
Utilization of cross-linked la ...... ndocrine-disrupting chemicals.
@en
P2093
Hubert Cabana
J Peter Jones
P304
P356
10.1002/BIT.22198
P577
2009-04-01T00:00:00Z